Fuji Pharma Co., Ltd. (FUP) Revenue
0 Followers
Fuji Pharma Co., Ltd. Revenue
Fuji Pharma Co., Ltd. had a revenue of 15.67B in the quarter ending Jun 30, 2026, with 13.37%. This bring the company's revenue in the last twelve months to 60.10B, Increased 4.90%. In the fiscal year ending Sep 30, 2025, Fuji Pharma Co., Ltd. had annual revenue of 51.68B with 12.01% growth.
- Revenue (ttm)
- 60.10B
- Revenue Growth
- 8.84%
- P/S Ratio
- 0.01
- Revenue/Employee
- EUR 29,361,932
- Employees
- 1,760
- Market Cap
- EUR 277.06M
Revenue Chart
Fuji Pharma Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 51.68B | 5.54B | 12.01% |
| Sep 30, 2024 | 46.14B | 5.25B | 12.84% |
| Sep 30, 2023 | 40.89B | 5.46B | 15.42% |
| Sep 30, 2022 | 35.43B | 1.44B | 4.22% |
| Sep 30, 2021 | 33.99B | 197.00M | 0.58% |
| Sep 30, 2020 | 33.79B | -2.49B | -6.85% |
| Sep 30, 2019 | 36.28B | -1.63B | -4.30% |
| Sep 30, 2018 | 37.91B | 2.52B | 7.13% |
| Sep 30, 2017 | 35.39B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.